In addition, T cell-intrinsic loss of CDK6 does not affect anti-viral and anti-tumor responses in vivo. Our data provide first insights into a potential dual function of CDK6 in regulating type I IFN signaling in CD8+ T cells, promoting both interferon-stimulated gene (ISG) expression but also negative feedback loops. This evidence concerns the gene CDK6 and neoplasm.